Immunotherapy & thoracic cancers
نویسندگان
چکیده
منابع مشابه
Immunotherapy in Gastrointestinal Cancers
Gastrointestinal cancers represent a major public health problem worldwide. Immunotherapeutic strategies are currently under investigation in this setting and preliminary results of ongoing trials adopting checkpoint inhibitors are striking. Indeed, although a poor immunogenicity for GI has been reported, a strong biological rationale supports the development of immunotherapy in this field. The...
متن کاملImmunotherapy for Lung Cancers
Lung cancer is the leading cause of cancer-related deaths worldwide. Although treatment methods in surgery, irradiation, and chemotherapy have improved, prognosis remains unsatisfactory and developing new therapeutic strategies is still an urgent demand. Immunotherapy is a novel therapeutic approach wherein activated immune cells can specifically kill tumor cells by recognition of tumor-associa...
متن کاملViroimmunotherapy of Thoracic Cancers
Thoracic cancers, including non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), and malignant pleural mesothelioma (MM), cause the highest rate of cancer mortality worldwide. Most of these deaths are as a result of NSCLC; however, prognoses for the other two diseases remain as some of the poorest of any cancers. Recent advances in immunotherapy, specifically immune checkpoint inh...
متن کاملImmunotherapy of Brain Cancers and Neurological Disorders
Submit Manuscript | http://medcraveonline.com Abbreviations: α-syn: α-synucleinopathies; Aβ: Amyloid Beta; AD: Alzheimer’s Disease; ALL: Acute Lymphoblastic Leukemia; ALS: Amyotrophic Lateral Sclerosis; BBB: Blood Brain Barrier; BPB: Brain Protective Barriers; CAR: Chimeric Antigen Receptor; CLL: Chronic Lymphocytic Leukemia; CNS: Central Nervous System; CSF: Cerebro-Spinal Fluid; CTLA: Cytotox...
متن کاملRare thoracic cancers, including peritoneum mesothelioma.
Rare thoracic cancers include those of the trachea, thymus and mesothelioma (including peritoneum mesothelioma). The aim of this study was to describe the incidence, prevalence and survival of rare thoracic tumours using a large database, which includes cancer patients diagnosed from 1978 to 2002, registered in 89 population-based cancer registries (CRs) and followed-up to 31st December 2003. O...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Thoracic Disease
سال: 2018
ISSN: 2072-1439,2077-6624
DOI: 10.21037/jtd.2017.12.137